Arjuna Capital cut its position in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 87.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,682 shares of the medical research company’s stock after selling 11,381 shares during the quarter. […]